RxDoctor Payments Data

Nicholas Dailey, PA

Physician Assistant · Ronceverte, WVNPI 1033519194

Payments from drug & device makers

$593in general payments, 2019–2025

Across 33 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$133
  • AbbVie$129
  • Pfizer$101
  • Bayer$77
  • Amgen$67
  • Phathom Pharmaceuticals, Inc.$49
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk8$133
AbbVie5$129
Pfizer6$101
Bayer5$77
Amgen4$67
Phathom Pharmaceuticals, Inc.3$49
GSK1$20
Lilly USA, LLC1$17

How this compares

$593 in reported general payments places this provider in the 65th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$5,163
Medicare patients
75
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$28,738
JardianceEmpagliflozin16$19,498
LinzessLinaclotide22$12,078
VascepaIcosapent Ethyl13$4,532
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,047
Gabapentin114$1,739
Atorvastatin Calcium128$1,184
Metoprolol Succinate52$1,131
Omeprazole105$824
Albuterol Sulfate HfaAlbuterol Sulfate31$798
Levothyroxine Sodium95$781
Famotidine63$771
Duloxetine Hcl48$635
Tamsulosin Hcl58$629
Rosuvastatin Calcium52$596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$101$28,73830 claims
AbbVieLinzess$129$12,07822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Ronceverte

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →